If you’re worried about the cost of prescription medications, you’re not alone. Rising drug prices continue to strain the budgets of many older Americans, especially those living on fixed incomes.

Expanding Medicare’s prescription drug negotiation program could save the program nearly $200 billion while helping hold down prescription drug costs for consumers, a new AARP report says.

The report comes as many Medicare beneficiaries are also wondering whether their Part D prescription drug premiums could increase next year after a temporary federal subsidy program ends. AARP is urging federal officials to do what they can to help keep prescription drug coverage affordable.

At the same time, the Trump administration has continued to promote efforts to lower prescription drug prices, including expanding “most favored nation” pricing for some medications. While the long-term impact of those efforts is still unfolding, most people just want affordable medications they can count on.

For now, experts recommend reviewing your Medicare Part D coverage each year during Open Enrollment, comparing plan options and talking with your doctor or pharmacist about lower-cost alternatives.

Prescription drug affordability remains a concern for millions of Americans. Understanding the changes—and reviewing your coverage annually—can help you make informed decisions.

Are high prescription drug costs affecting you or someone you love? Share your experiences, concerns and ideas with Voices for Affordable Health.

---